CompletedNot Applicable

COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes

United States105 participantsStarted 2020-11-17

Plain-language summary

This is a prospective cohort study of pregnant patients at an urban academic center diagnosed with perinatal COVID-19 infection, followed up to 6 weeks postpartum.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of COVID-19 in pregnancy or within 6 months post partum * Planned delivery at Thomas Jefferson University Hospital Exclusion Criteria: * Declines routine COVID testing on admission * In active labor/pain/otherwise unable to provide consent

What they're measuring

Maternal COVID-19 serology (IgG and IgM)

Timeframe: 6 weeks post partum

Maternal/neonatal IgG and IgM concordance

Timeframe: Delivery

Maternal COVID serology time/profile following vaccination

Timeframe: 6 months

Breastmilk Serology

Timeframe: 6months

Trial details

NCT IDNCT04659759

SponsorThomas Jefferson University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-30

View on ClinicalTrials.gov More Covid19 trials